- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 235/14 - Radicals substituted by nitrogen atoms
Patent holdings for IPC class C07D 235/14
Total number of patents in this class: 282
10-year publication summary
|
17
|
18
|
18
|
23
|
19
|
15
|
15
|
16
|
13
|
5
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Actelion Pharmaceuticals Ltd | 484 |
6 |
| LG Chem, Ltd. | 17970 |
5 |
| The General Hospital Corporation | 4890 |
5 |
| X4 Pharmaceuticals, Inc. | 96 |
5 |
| Calico Life Sciences LLC | 118 |
5 |
| VALO Health, Inc. | 195 |
5 |
| Centre National de La Recherche Scientifique | 11111 |
4 |
| Kyoto University | 2934 |
4 |
| Nippon Shinyaku Co., Ltd. | 324 |
4 |
| Cavion, Inc. | 22 |
4 |
| The Regents of the University of California | 20902 |
3 |
| Janssen Pharmaceutica N.V. | 3147 |
3 |
| Allergan, Inc. | 2148 |
3 |
| Sumitomo Chemical Company, Limited | 8965 |
3 |
| Takeda Pharmaceutical Company Limited | 2700 |
3 |
| Antabio SAS | 23 |
3 |
| Concert Pharmaceuticals, Inc. | 242 |
3 |
| Epizyme, Inc. | 360 |
3 |
| Kaken Pharmaceutical Co., Ltd. | 107 |
3 |
| MEI Pharma, Inc. | 42 |
3 |
| Other owners | 205 |